Established under the Eurostars E9215 (IMAID) program, Redoxis can now offer magnetic resonance imaging services in animal models. Redoxis offer, together with Image Analysis group and Lund University Bioimaging Center a service for efficacy evaluation of new drugs for autoimmune conditions. Redoxis offer standardised in vivo imaging models with relevance for autoimmune diseases including RA […]
Malin H Hopkins (CEO) will be present at BioEurope Spring taking place in Amsterdam 12-14th of March. We continuously add more models to our portfolio and are looking forward to many new interactions and discussions on how we can assist in your preclinical research. Send Malin an email or book a one-to-one meeting for an […]
Redoxis is now proud to offer models of Psoriasis (IMQ model) and Psoriatic Arthritis (MiP) model. Psoriasis is a common autoimmune disease affecting the skin but up to a third of the patients also have involvement of other organs such as joints resulting in psoriatic arthritis. For more information on our models for these diseases […]
We are, since december, happy to have Frida on our team of researchers. Frida just finished her master in molecular biology at the University of Lund with a focus on immunology and neurobiology and will strengthen our in vivo team. Welcome Frida!
Applications are invited for 14 ESRs (Early Stage Researchers) funded by the Marie-Sklodowska-Curie Innovative Training Network COSMIC (Combatting disorders of adaptive immunity with systems medicine; project 765158) within the European Horizon 2020 Programme. COSMIC is an international consortium of high profile universities, research institutions and companies located in Germany, Italy, France, Greece, the United Kingdom, […]